ISSN: 0893-133X

Journal Home

Journal Guideline

Neuropsychopharmacology Q1 Unclaimed

Nature Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Neuropsychopharmacology is a journal indexed in SJR in Pharmacology and Psychiatry and Mental Health with an H index of 249. It has a price of 3690 €. It has an SJR impact factor of 2,743 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,743.

Neuropsychopharmacology focuses its scope in these topics and keywords: effects, chronic, deficits, modulates, receptor, healthy, treatment, activation, hippocampus, psychosis, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Pharmacology (Q1) Psychiatry and Mental Health (Q1)

Price

3690 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

2,743

SJR Impact factor

249

H Index

254

Total Docs (Last Year)

861

Total Docs (3 years)

15881

Total Refs

5626

Total Cites (3 years)

715

Citable Docs (3 years)

5.84

Cites/Doc (2 years)

62.52

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Pharmacological Reviews Q1
Drug Resistance Updates Q1
Annual Review of Pharmacology and Toxicology Q1
Molecular Therapy Q1
Journal for ImmunoTherapy of Cancer Q1

Compare this journals

Aims and Scope

Best articles by citations

Altered HPA Axis Responsivity to Metyrapone Testing in Methadone Maintained Former Heroin Addicts with Ongoing Cocaine Addiction

Putamen Mitochondrial Energy Metabolism Is Highly Correlated to Emotional and Intellectual Impairment in Schizophrenics

Does Ketamine-Mediated N-methyl-D-aspartate Receptor Antagonism Cause Schizophrenia-like Oculomotor Abnormalities?

Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients

Enhancement of Postsynaptic Sensitivity to Dopaminergic Agonists Induced by Neonatal Hippocampal Lesions

Hypothalamic Regulation of Sleep

The 5HT1Dbeta Receptor Gene in Bipolar Disorder A Family-based Association Study

The Effects of an Alpha-2 Adrenergic Agonist, Guanfacine, on rCBF in Human Cortex in Normal Controls and Subjects with Focal Epilepsy

Differential Distribution of Corticotropin-Releasing Hormone Immunoreactive Axons in Monoaminergic Nuclei of the Human Brainstem

Hypothalamic-pituitary-adrenal Axis Dysregulation in Depersonalization Disorder

Tetraspan Protein CD151 A Common Target of Mood Stabilizing Drugs?

Serotonin 5-HT1A Receptor Binding Potential Declines with Age as Measured by [11C]WAY-100635 and PET

SHOW MORE ARTICLES

Genetic Factors Involved in the Effects of Developmental Low-Level Alcohol Induced Behavioral Alterations in Rats

A Comparison of the Effects of Intravenous Pentagastrin on Patients with Social Phobia, Panic Disorder and Healthy Controls

Regulation of Sensorimotor Gating of the Startle Reflex by Serotonin 2A Receptors Ontogeny and Strain Differences

Conditioning to Injection Procedures and Repeated Testing Increase SCH 23390-Induced Catalepsy in Mice

Subtypes of Family History and Conduct Disorder Effects on P300 During the Stroop Test

beta-blocker Binding to Human 5-HT1A Receptors in vivo and in vitro Implications for Antidepressant Therapy

Role of the Dorsomedial Hypothalamus in Mediating the Response to Benzodiazepines on Trial 2 in the Elevated Plus-Maze Test of Anxiety

Noribogaine Generalization to the Ibogaine Stimulus Correlation with Noribogaine Concentration in Rat Brain

Involvement of the Nucleus Accumbens and Medial Prefrontal Cortex in the Expression of Conditioned Hyperactivity to a Cocaine-Associated Environment in Rats

Timing is Everything

Effects of the Prolyl Endopeptidase Inhibitor S 17092 on Cognitive Deficits in Chronic Low Dose MPTP-Treated Monkeys

Chronic Dopamine D1, Dopamine D2 and Combined Dopamine D1 and D2 Antagonist Treatment in Cebus Apella Monkeys Antiamphetamine Effects and Extrapyramidal Side Effects